(Q44034807)

29 November 2017

title

Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension (English)

1 reference

29 November 2017

Carlos M Ferrario

1

1 reference

29 November 2017

Ronald D Smith

2

1 reference

29 November 2017

Bridget Brosnihan

3

1 reference

29 November 2017

Mark C Chappell

4

1 reference

29 November 2017

Vito M Campese

5

1 reference

29 November 2017

Ole Vesterqvist

6

1 reference

29 November 2017

Wei-chi Liao

7

1 reference

29 November 2017

Michael C Ruddy

8

1 reference

29 November 2017

Clarence E Grim

9

1 reference

29 November 2017

language of work or name

1 reference

1 June 2002

1 reference

Journal of Clinical Hypertension

29 November 2017

published in

1 reference

29 November 2017

volume

15

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

557-564

1 reference

Salt sensitivity in hypertension. Renal and cardiovascular implications

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

21 January 2018

Salt and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Counterregulatory actions of angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Pathways of angiotensin-(1-7) metabolism in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Plasma renin concentration in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Effect of captopril and enalapril on endothelial function in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Angiotensin I-converting enzyme isoforms (high and low molecular weight) in urine of premature and full-term infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Prolylcarboxypeptidase (angiotensinase C) in human lung and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

Impact of salt intake on blood pressure and proteinuria in diabetes: importance of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Differential response of angiotensin peptides in the urine of hypertensive animals

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Antihypertensive and antihypertrophic effects of omapatrilat in SHR

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Relation between plasma renin activity, angiotensin, and aldosterone and blood pressure in mild untreated hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Determinants of angiotensin II generation during converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902268-9

7 January 2021

10.1016/S0895-7061(02)02268-9

Identifiers

DOI

1 reference

29 November 2017

1 reference